Skip to main content
Premium Trial:

Request an Annual Quote

Biolog Wins NIH Grant to Study Yeast Genes; Partners with Johns Hopkins

NEW YORK, Oct. 25 (GenomeWeb News) - Biolog has won an STTR grant from the US National Institutes of Health to study genes in yeast using its microarray technology, the company said today.


Biolog will conduct the study in collaboration with researchers at the HighThroughputBiologyCenterat JohnsHopkinsUniversity. Biolog, based in Hayward, Calif., plans to use its Phenotype MicroArray technology to study gene function in baker's yeast.


The amount of the grant was not immediately available from the company but the NIH database lists a $123,000 grant to Biolog entitled "Phenotyping all genes of S. cerevisiae." Biolog said that it has announced a total of $7 million in SBIR and STTR funding from NIH and NASA for its microarray technology so far.


The award comes one week after Biolog won an NIH grant to develop its Phenotype MicroArray technology against fastidious pathogens such as Helicobacter pylori and Campylobacter jejuni, the causes of peptic ulcers and certain food poisonings.


The amount of the grant was not disclosed.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.